Nataline Mary Sarkisyan (July 10, 1990 – December 20, 2007) was an American teenager with recurrent leukemia. Her case became part of the health care reform debate in the United States in 2007 when Cigna HealthCare denied coverage for a liver transplant operation. The company later reversed its decision after a great deal of media attention to her story, but Sarkisyan died hours later. Background Sarkisyan was born to an Armenian-American family. She was diagnosed with leukemia at age 14. She was covered under her father's health insurance, through his employer, Mercedez-Benz. The employer plan was administered by Cigna HealthCare. During her treatment for leukemia, her liver deteriorated. Sarkisyan's doctors at the UCLA Medical Center told the family and Cigna that they recommended a liver transplant, and patients in similar circumstances have a six-month survival rate of 65%. Different doctors gave different estimates of the likelihood of success. Dr. John Roberts, chief of the transplant service at UC San Francisco (not the transplant center treating Sarkisyan), said that his center generally does not accept a patient without a 50% or greater five-year survival rate. Dr. Goran Klintmalm, chief of the Baylor Regional Transplant Institute in Dallas, said this particular operation was a "very high-risk transplant," but that he would consider the same operation on a similar patient. On December 11, 2007, Cigna rejected the request for coverage for the liver transplant. Sarkisyan's doctors at UCLA, including the head of its transplant unit, wrote a letter to protest that the treatment proposed was neither experimental nor unproven and called on Cigna to urgently review its decision. Cigna HealthCare refused to pay for treatment by citing policy provisions which do not cover services considered experimental, investigational and/or unproven to be safe and/or effective for the patient. Cigna said that it had no financial stake in the decision because it only administered the insurance plan and would not bear the cost of any operation. The cost of a liver transplant and one year of follow-up care was $450,000 in 2005. UCLA declined two livers while waiting for insurance approval from Cigna. Ms. Sarkisyan's family was also informed that they could proceed with the transplant if they could make a down-payment of $75,000. Among the groups who publicly spoke out against Cigna's decision was the California Nurses Association/National Nurses Organizing Committee. Wendell Potter, a Cigna PR executive, advised the board to cover the cost